Plain-English translation of NCT07065552 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing a medication called — a drug typically used to help people lose weight — to see if it can slow down the growth of endometrial cancer cells. Researchers will compare cancer tissue samples taken before and after you take the medication to measure whether it actually works. You would take this treatment for 4 weeks before your planned surgery to remove your uterus.
Obesity is known to increase the risk and severity of endometrial cancer, and current treatments don't always address this underlying connection. This trial is exploring whether this medication, which helps with weight loss, might also directly fight the cancer itself.
You likely qualify if…
You likely don't qualify if…
You would start taking the medication and come in for a biopsy (tissue sample) before treatment begins. You'll take the medication for 4 weeks, then have your planned surgery as usual — your surgeon will collect another tissue sample during that operation so researchers can compare how the cancer changed. After finishing the medication, you'll have one follow-up visit, and then the study team will check in on your health and weight loss through your medical records for 2 years.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States